Leaflet IMURAN 50mg film-coated tablets

Product code:
W60846001
Quantity:
100
Indicated for:
immunosuppression
Route of administration:
oral
Substance:
azathioprine (immunosuppressant)
ATC
L04AX01 — Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Other immunosuppressants

Precautions:

Avoid live vaccines

Avoid live vaccines during treatment if contraindicated.

Immunosuppression / infection risk

This medicine may increase the risk of infections.

Major drug interactions

This medicine may have important interactions with other medicines.

Myelosuppression / agranulocytosis

This medicine may lower blood cell counts.

Breastfeeding warning

Use during breastfeeding only on medical advice.

Pregnancy warning

Use during pregnancy only on medical advice.

Genetic test recommended

A genetic test may be needed before treatment.

Azathioprine is an immunosuppressive agent used in the treatment of autoimmune diseases such as rheumatoid arthritis, systemic lupus erythematosus, and inflammatory bowel diseases (Crohn's disease and ulcerative colitis). It is also used to prevent organ rejection following transplants, particularly kidney transplants.

Azathioprine works by inhibiting purine synthesis, reducing the proliferation of T and B lymphocytes, and suppressing the immune response. It is administered orally or intravenously, with the dose adjusted based on body weight and patient response.

Common side effects include nausea, vomiting, diarrhea, and bone marrow suppression, which can lead to anemia, leukopenia, and thrombocytopenia. In rare cases, severe adverse reactions such as hepatotoxicity, pancreatitis, or an increased risk of infections and malignancies may occur. Regular monitoring of hematological and hepatic parameters is essential during treatment.

Azathioprine is an effective therapeutic option for managing autoimmune diseases and preventing organ rejection, contributing to improved quality of life for patients.

General data about IMURAN 50mg

Substance:
azathioprine
Date of latest medicines list:
01-06-2026
Product code:
W60846001
Concentration:
50mg
Pharmaceutical form:
film-coated tablets
Quantity:
100
Product type:
Original
Price:
67.06 RON
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:
EXCELLA GMBH & CO. KG - GERMANIA
Holder:
ASPEN PHARMA TRADING LIMITED - IRLANDA
Number:
10042/2017/01
Shelf life:
5 years

Concentrations available for azathioprine

  • 100mg
  • 25mg
  • 50mg
  • 75mg

Compensation lists for IMURAN 50mg Aspen

B - Sublist B with 50% discount from the reference price

Price
67.06 RON
Copayment
33.53 RON
Patient
33.53 RON

G13 (C1) - Myasthenia gravis

Price
67.06 RON
Copayment
67.06 RON
Patient
0.00 RON

G14 (C1) - Multiple sclerosis

Price
67.06 RON
Copayment
67.06 RON
Patient
0.00 RON

G17 (C1) - Major collagenosis (systemic lupus erythematosus, scleroderma)

Price
67.06 RON
Copayment
67.06 RON
Patient
0.00 RON

G18 (C1) - Rheumatoid arthritis, psoriatic arthropathy, severe chronic psoriasis and juvenile arthritis

Price
67.06 RON
Copayment
67.06 RON
Patient
0.00 RON

G25 (C1) - Chronic renal failure

Price
67.06 RON
Copayment
67.06 RON
Patient
0.00 RON

G27 (C1) - Pemphigus

Price
67.06 RON
Copayment
67.06 RON
Patient
0.00 RON

G5 (C1) - Autoimmune hepatitis

Price
67.06 RON
Copayment
67.06 RON
Patient
0.00 RON

GX (C1) - GENERIC (used in compensation list, C1, for another diagnosis)

Price
67.06 RON
Copayment
67.06 RON
Patient
0.00 RON

NHP 4.A (C2) - Multiple sclerosis

Price
67.06 RON
Copayment
67.06 RON
Patient
0.00 RON

NHP 9.4 (C2) - Kidney transplant, combined kidney and pancreas transplant

Price
67.06 RON
Copayment
67.06 RON
Patient
0.00 RON

NHP 9.6 (C2) - Lung transplant

Price
67.06 RON
Copayment
67.06 RON
Patient
0.00 RON

NHP 9.7 (C2) - Outpatient treatment of transplant patients

Price
67.06 RON
Copayment
67.06 RON
Patient
0.00 RON